Navigation Links
Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement
Date:12/18/2007

EAST SETAUKET, N.Y., Dec. 18 /PRNewswire-FirstCall/ -- Lixte Biotechnology Holdings, Inc. (OTC Bulletin Board: LIXT) a developer of improved methods for both detection and treatment of cancer, announced the closing of a private placement. In the placement, Lixte sold 1,000,000 shares of its Common Stock at a price of $0.65 per share resulting in gross proceeds of $650,000. WestPark Capital, Inc. acted as placement agent and received $65,000 in commissions and $26,000 representing a non-accountable expense fee. Lixte also issued to WestPark five year warrants to purchase up to 100,000 shares of the Company's Common Stock and five year incentive warrants to purchase up to an additional 20,000 shares, all such warrants to be exercisable at $0.65 per share.

Lixte agreed to file a registration statement with the SEC covering resale of the shares upon written request from holders who represent at least 50% of the shares. Lixte also granted to the holders piggyback registration rights.

John Kovach, Lixte's President, stated that Lixte intends to use the net proceeds to pursue development of proprietary compounds for the submission of an IND to the Food & Drug Administration for a Phase I clinical trial, and for working capital.

The offer and sale of the shares sold were not registered under the Securities Act of 1933, as amended in reliance upon the exemption from registration contained in Section 4(2) of the Securities Act and Regulation D promulgated thereunder. The shares sold by Lixte may not be reoffered or sold in the United States by the holders in the absence of an effective registration statement, or exemption from the registration requirements, under the Securities Act.

About Lixte

Lixte is a cancer therapeutics and diagnostics company. Founded as a biomarker-diagnostics company in 2005, the Company develops new chemotherapy drugs targeting molecular abnormalities of common human cancers. Over the past year, based on the
'/>"/>

SOURCE Lixte Biotechnology Holdings, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
2. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... 20, 2014 Reportlinker.com announces that a ... catalogue: Global Patient Scales Industry ... report analyzes the worldwide markets for Patient Scales ... Floor Scales, Infant & Baby Scales, Chair Scales, ... comprehensive analytics for the US, Canada, Japan, Europe, ...
(Date:8/19/2014)...   Lincor Inc. today announced an ... New Jersey -based healthcare system ... will deploy Lincor,s PatientLINC technology across its three-hospital ... Hoboken University Medical Center. Lincor,s LINC ... to help hospitals reach new levels of patient ...
(Date:8/19/2014)... 2014 /PRNewswire-iReach/ -- ChemImage founder and CTO, Patrick ... describing an innovative diagnostic procedure for the detection of ... on Disease (SPEC) conference in Krakow, Poland ... "Development of in vitro Diagnostics for Detection of Colorectal ... the conference poster session on Tuesday, August 19, 2014 ...
Breaking Medicine Technology:Global Patient Scales Industry 2Global Patient Scales Industry 3Global Patient Scales Industry 4Global Patient Scales Industry 5Global Patient Scales Industry 6Global Patient Scales Industry 7Global Patient Scales Industry 8Global Patient Scales Industry 9Global Patient Scales Industry 10Global Patient Scales Industry 11Global Patient Scales Industry 12Global Patient Scales Industry 13Global Patient Scales Industry 14Global Patient Scales Industry 15Global Patient Scales Industry 16Global Patient Scales Industry 17Global Patient Scales Industry 18Global Patient Scales Industry 19Lincor Announces Agreement With CarePoint Health For State-Of-The-Art Patient Engagement Technology 2ChemImage Scientists Present Latest Developments for in vitro Detection of Colorectal Cancer Using Raman Molecular Imaging (RMI) at International Conference Focused on Biomedical Applications of Raman Spectroscopy 2
(Date:8/20/2014)... Thompson HealthDay Reporter WEDNESDAY, ... older women avoid a condition that causes a life-threatening irregular ... had a 10 percent lower risk of developing atrial fibrillation, ... the Aug. 20 issue of the Journal of the ... against the heart rhythm disorder even if they were obese, ...
(Date:8/20/2014)... Park Cities Pet Sitter , Inc. has announced ... donation drive that benefits the animal shelter and rescue communities. ... with the Humane Society of the United States’ Animal Shelter ... , As part of their participation, Park Cities Pet Sitter ... the Presents 4 Pets drive from their client base, as ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 With 3943.8% growth, ... list of the nation’s fastest growing companies. The Inc. 500 ... health care sector. Connexion Point is the #1 fastest growing ... in Medicare and Medicaid, and its clients include four of ... Point employs 1,000 people and has offices and contact centers ...
(Date:8/20/2014)... common cause of endophthalmitis, a potentially blinding condition that ... injections, are the well-known staphylococci ("staph") and ... study published in the August issue of Ophthalmology ... of cases at New York Eye and Ear Infirmary ... found that gram-positive bacteria, which include staph and strep ...
(Date:8/20/2014)... August 20, 2014 The non-small cell ... considerably in the offing across the top 8 developed ... 2013 to around USD 8 billion by 2020-end, posting ... growth is projected to be driven by innovative therapies ... currently lacking efficient treatment, unlike the non-squamous segment. Thus, ...
Breaking Medicine News(10 mins):Health News:Exercise May Guard Against Irregular Heartbeat in Older Women 2Health News:Exercise May Guard Against Irregular Heartbeat in Older Women 3Health News:Dallas-based Park Cities Pet Sitter Announces Participation in the 2014 National Association of Professional Pet Sitters “Presents 4 Pets” Program 2Health News:Dallas-based Park Cities Pet Sitter Announces Participation in the 2014 National Association of Professional Pet Sitters “Presents 4 Pets” Program 3Health News:Dallas-based Park Cities Pet Sitter Announces Participation in the 2014 National Association of Professional Pet Sitters “Presents 4 Pets” Program 4Health News:With 3943.8% Growth, Connexion Point, a Leader in Contact Centers for Health Care, Ranks 86th on the Inc. 500 List as One of the Nation’s Fastest Growing Companies 2Health News:Researchers pinpoint most common causes of dangerous eye infection post surgery and trauma 2Health News:Researchers pinpoint most common causes of dangerous eye infection post surgery and trauma 3Health News:Top 8 Developed Nations NSCLC Market to Grow at CAGR of 6.6% Through 2020, Says GBI Research in Its Report Published at MarketPublishers.com 2Health News:Top 8 Developed Nations NSCLC Market to Grow at CAGR of 6.6% Through 2020, Says GBI Research in Its Report Published at MarketPublishers.com 3Health News:Top 8 Developed Nations NSCLC Market to Grow at CAGR of 6.6% Through 2020, Says GBI Research in Its Report Published at MarketPublishers.com 4
... , CINCINNATI , Feb. ... works through the immune system to regenerate damaged kidney tissues ... a number of organs. , The findings, reported in this ... from collaborative research led by Cincinnati Children,s Hospital Medical Center ...
... narcolepsy Individuals with the sleep disorder narcolepsy suffer ... by strong emotions (a condition known as cataplexy). It is ... it is caused by the individual,s immune system attacking certain ... been proven definitively. However, Mehdi Tafti and colleagues, at the ...
... buttons to stop closing doors , MONDAY, Feb. 15 ... injuries each year in the United States, and three-quarters of ... large-scale study of these events. , Slips, trips and falls ... one-third were caused by elevator doors closing on a person. ...
... bariatric procedures, use of revisions will grow, study finds ... surgery carries a higher risk of complications than the ... surgical treatment, known as bariatric surgery, is the only ... people. Rates of repeat bariatric surgery are reported to ...
... , RESTON, Va. , Feb. 15 ... digital world, today released a study of online health insurance activity in ... insurance site in Q4 2009, representing 10 percent of the total U.S. ... the complimentary comScore webinar, The Online Health Insurance Landscape, on ...
... them as new treatments for heart disease, other conditions ... identified several drugs that can change the way cells ... used to treat heart attack, stroke and other conditions. ... naturally during development and in response to demanding activities ...
Cached Medicine News:Health News:Scientists Discover Molecular Pathway for Organ Tissue Regeneration and Repair 2Health News:Scientists Discover Molecular Pathway for Organ Tissue Regeneration and Repair 3Health News:JCI online early table of contents: Feb. 15, 2010 2Health News:JCI online early table of contents: Feb. 15, 2010 3Health News:JCI online early table of contents: Feb. 15, 2010 4Health News:JCI online early table of contents: Feb. 15, 2010 5Health News:JCI online early table of contents: Feb. 15, 2010 6Health News:Elevators Can Bring Injury to Seniors 2Health News:Repeated Weight-Loss Surgery Carries Added Risks 2Health News:One in Ten Americans Visited a Health Insurance Site in Q4 2009 2Health News:One in Ten Americans Visited a Health Insurance Site in Q4 2009 3Health News:One in Ten Americans Visited a Health Insurance Site in Q4 2009 4Health News:Drugs That Shift Cell's Energy Find New Purpose 2
Hard protective shields for post-operative or post-injury use. Universal, or Left/Right specific. Packaged 12 per box....
... a broad selection of tip ... wide variety of ophthalmic procedures. ... packaged sterile, complete with a ... in the "off " position ...
... Accu-Temp® Cauteries provide a broad ... in a wide variety of ophthalmic ... packaged sterile, complete with a safety ... "off " position when not in ...
... a broad selection of tip styles ... of ophthalmic procedures. Each single use ... a safety cap to lock switch ... not in use, and carries a ...
Medicine Products: